March 12, 2022
1 minute read
NuVasive Inc. announced increased net sales for the fourth quarter and full year 2021, including double-digit growth in international net sales, according to a press release.
NuVasive reported net sales of $302.1 million in the fourth quarter of 2021, an increase of 3.5% over the prior year period. The company also reported total net sales of $1.139 billion for the full year of 2021, an increase of 8.4% over 2020. NuVasive attributed the increase in net sales to the success of the Pulse platform and the C360 portfolio, which includes the Simplify Cervical Disc, according to the release.
“In 2021, we made significant progress in our strategy to deliver multiple vectors of growth, despite challenges related to the COVID-19 pandemic,” Chris Barry, CEO of NuVasive, said in the release. “Our results reflect the organization’s continued evolution from a pioneer in lateral spine surgery to a company at the forefront of procedural innovation across the spine continuum and on a growing global scale. Through our focus on consistent execution and our commitment to increasing shareholder value, our investments have built a technology pipeline that paves the way for sustainable growth in 2022 – and for years to come.